Research | OneLook Acronym Finder |
Serial Number | 98195945 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Christina Licursi |
Attorney Docket Number | R08262000101 |
2023-09-25 | Application Filed |
2023-10-10 | Location: NEW APPLICATION PROCESSING |
2023-10-10 | Status: Live/Pending |
2023-10-10 | Transaction Date |
Owner: | Remix Therapeutics Inc. |
Address | 400 Technology Square Cambridge DE 02139 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for gene therapy and gene modulation; pharmaceutical compositions and therapeutic products in the nature of chemical and biological small molecules to degrade RNA, enhance expression, induce exon skipping, and rescue genetic lesions; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; Medical diagnostic apparatus for testing and sequencing DNA and RNA in the fields of genetics, genomics, gene modulation and genetic engineering; medical and scientific research in the fields of genetics, genomics, gene modulation and genetic engineering; DNA and RNA analysis and sequencing services for scientific and research purposes; research, development and consultancy in the field of genomics and gene modulation; Testing, inspection, research, and development of pharmaceutical preparations for gene modulation; Development of pharmaceutical preparations for use in gene modulation; laboratory research in the fields of genetics, gene modulation, drug development; Genomic analysis and sequencing services for medical purposes; DNA and RNA analysis and sequencing services for medical purposes |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-10-10 | 1 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2024-05-16 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2024-05-17 | 3 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2024-05-17 | 4 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-05-17 | 5 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-06-26 | 6 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-06-26 | 7 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-06-26 | 8 TEME I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2024-06-27 | 9 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2024-06-27 | 10 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-06-27 | 11 GNRN O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.